Cited by 66Mobile Health and mHealth ApplicationsDiabetes Management and ResearchDiabetes Management and Education

Reviewing U.S. connected diabetes care: the newest member of the team

Open access
Levine, Brian J., Close, Kelly L., Gabbay, Robert A.·2020·Diabetes Technology & Therapeutics

Abstract

Recent years have brought about an explosion in the number of companies offering connected diabetes care products, defined as digital diabetes management systems based around (1) smartphone apps, (2) devices with built-in connectivity, and (3) remote human and automated coaching and support. These nascent models aim to provide more continuous and on-demand care, aligning with the 24/7 demands of chronic disease. It has been enabled by multiple factors, including the rising use of connected devices and apps to help people manage their chronic conditions, growing appreciation for the importance of outcomes beyond A1c, and the lofty and growing cost of health care. Despite the potential of these programs to improve the outcomes and well-being of people with diabetes and reduce the burdens on health care providers and systems, awareness and use of these programs and approaches remain low in the medical community. In this article, we present a snapshot of this dynamic field, including a taxonomy of various connected diabetes care products available to employers, health plans, health systems, and people with diabetes in the United States, and we identify meaningful distinctions among them: (1) health conditions managed, (2) peer support interactions, (3) prescribing providers on the care team, (4) provision of connected medical devices and/or continuous glucose monitors, (5) degree of treatment personalization, and (6) clinical and real-world evidence. We also discuss broad trends in connected diabetes care. Given the urgency and scale of the diabetes epidemic, it is vital that a range of medical and clinical communities find meaningful ways to scale individualized, timely care under reimbursement models that better align incentives for various stakeholders, particularly health care providers themselves. This would not only address deficiencies in care but could also make diabetes care more attractive to future clinicians.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/dia.2019.0273

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other online programs assist in improving diabetes outcomes by remotely monitoring clinical data and providing feedback and coaching.

    “Others assist in improving diabetes outcomes by remotely monitoring clinical data (for instance, wireless monitoring of glucose levels, weight, or blood pressure) and providing feedback and coaching (266-271).”

    From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [271]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Dixon RF, Miller DP, Evans KL, et al.: Real-world Gly- cemic Control Data from the Initial Launch of the Onduo Virtual Diabetes Clinic. American Diabetes Association Symposium on the Use of Real-World Data to Improve the Prevention and Care of Diabetes-Related Outcomes, Wa- shington, D.C, 2018.
  2. Osborn CY, Hirsch A, Heyman M, et al.: One drop im- proves A1c among people with type 2 diabetes. Ann Behav Med 2019;53:S1-S842.
  3. Uchida T, Takahashi H, Ban M, et al.: A Robot Counseling System-What Kinds of Topics Do we Prefer to Disclose to Robots? 26th IEEE International Symposium on Robot and Human Interactive Communication. Lisbon: IEEE, 2017. Address correspondence to:

Cited by

Sorted by citations

Authors
Levine, B. J., Close, K. L., & Gabbay, R. A.
Affiliations
  • Close Concerns (United States) (US)
  • Joslin Diabetes Center (US)
Corresponding author
Gabbay, Robert A.
Venue
Diabetes Technology & Therapeutics
Published
2020-01
Volume
22
Issue
1
Pages
1-9
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W2971669292
Cited by
66
References
24
Citations by year
2026: 5 · 2025: 4 · 2024: 9 · 2023: 9 · 2022: 10 · 2021: 16 · 2020: 13
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • Diabetes Technology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
digital health, mobile application, continuous glucose monitoring, peer support, remote coaching, chronic disease management, health care reimbursement, personalized treatment, employer health programs, health plans, health care system
MeSH terms
Wearable Electronic Devices, Blood Glucose, Diabetes Mellitus, Humans, Monitoring, Ambulatory, Disease Management, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review